Left Atrial Appendage Occlusion (Closure)

State-of-the-Art Assistance for People with AFib 

For people with non-valvular atrial fibrillation (AFib), the risk of stroke is of greater concern compared to the general population. In fact, one out of every six strokes in this country are attributed to AFib.

AFib is typically treated first with blood-thinning medication. This medication is not always tolerated long-term, and bleeding can become an undesirable side effect.

To help reduce the occurrence of stroke while keeping the risk of bleeding low, a left atrial appendage occlusion — or closure — device can be implanted through a small incision in the leg. This is a minimally-invasive technique and does not require open-heart surgery. The risk of stroke is reduced, while avoiding the side effects of blood thinners.

Wellstar is a leader in Georgia for this cutting-edge treatment. This nonsurgical technique is performed by a multidisciplinary team including an interventional cardiologist, a cardiac electrophysiologist and advanced cardiac imaging experts.

Learn more about Wellstar’s Structural Heart & Valve Program.